Previous 10 | Next 10 |
NEW YORK, NY / ACCESSWIRE / September 7, 2022 / Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Sema4 Holdings Corp. ("Sema4" or the "Company") (NASDAQ:SMFR) and reminds investors of the November 7, 2022 deadline to seek the role of...
NEW YORK, NY / ACCESSWIRE / September 2, 2022 / Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Sema4 Holdings Corp. ("SMFR" or the "Company") (NASDAQ:SMFR,SMFRW). If you suffered losses exceeding $50,000 investing in Sema4 stock ...
San Francisco, California--(Newsfile Corp. - August 22, 2022) - Hagens Berman urges Sema4 Holdings Corp. (NASDAQ: SMFR) investors who suffered significant losses to submit your losses now . Visit: www.hbsslaw.com/investor-fraud/SMFR Contact An Attorney Now: SMFR@hbsslaw.com 844-...
SAN FRANCISCO, Aug. 19, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Sema4 Holdings Corp. (NASDAQ: SMFR) investors who suffered significant losses to submit your losses now . Sema4 Holdings Corp. (NASDAQ: SMFR) Investigation: The investigation focuses on Sema4’s b...
Gainers: GreenBox ( GBOX ) +107% . Bed Bath & Beyond ( BBBY ) +55% . Artelo Biosciences ( ARTL ) +49% . Kirkland's ( KIRK ) +44% . SkyWater Technology ( SKYT ) +37% . fuboTV ( FUBO ) +33% . Ventyx Biosciences ...
Shares of Sema4 Holdings (NASDAQ: SMFR) are crashing today, down by 31.9% as of 11:08 a.m. ET. The steep decline came after the company provided its second-quarter update following the market close on Monday. Sema4 reported Q2 revenue of $36.2 million, down from $47 million in t...
Jefferies downgraded Sema4 Holdings ( NASDAQ: SMFR ) to Hold from Buy on Tuesday, noting a lower-than-expected revenue the health information company recorded for Q2 2022 with a cut to its full-year outlook. The firm also lowered the SMFR price target to $2 from $4. The ...
Gainers: Artelo Biosciences ( ARTL ) +31% . Ventyx Biosciences ( VTYX ) +23% . Eargo ( EAR ) +19% . Fulcrum Therapeutics ( FULC ) +18% . Genprex ( GNPX ) +17% . Losers: Albireo Pharma ( ALBO ) -25% . Sema4...
Save Foods ( SVFD ) -35% on pricing of $4.8M stock offering . Albireo Pharma ( ALBO ) -23% on Q2 earnings release . Tremor International ( TRMR ) -17% on Q2 earnings release . GAN ( GAN ) -17% on Q2 earnings release . Hel...
The following slide deck was published by Sema4 Holdings Corp. in conjunction with their 2022 Q2 earnings call. For further details see: Sema4 Holdings Corp. 2022 Q2 - Results - Earnings Call Presentation
News, Short Squeeze, Breakout and More Instantly...
Sema4 Holdings Corp. Company Name:
SMFR Stock Symbol:
NASDAQ Market:
Company expects to exceed 2022 revenue target with strong momentum to deliver continued growth in 2023 combining GeneDx and Centrellis ® platforms Company’s common stock will trade on the Nasdaq under new ticker “WGS” effective January 10, 2023 STAMFO...
STAMFORD, Conn., Dec. 30, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), a health insights company, today announced the company will participate in the 41 st Annual J.P. Morgan Healthcare Conference in San Francisco. Katherine Stueland , President and Chief Executive Officer, will del...
STAMFORD, Conn., Dec. 05, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), a health insights company, today announced the results of a new study on mitochondrial diseases in newborns. The findings support the addition of mitochondrial DNA (mtDNA) testing to rapid exome sequencing, showing it ca...